Redwood Capital Bancorp – 5-Star Rating – Small

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Redwood Capital Bancorp – 5-Star Rating – Small Business Lending Fund Redeemed – Cash Dividend Affirmed

EUREKA, Calif., Jan. 27, 2016 (GLOBE NEWSWIRE) -- REDWOOD CAPITAL BANCORP (OTCBB: RWCB ), the only locally owned and operated community bank holding company in Humboldt County, announced unaudited financial results for the three and twelve month periods ended December 31, 2015.  The community bank holding company reported record annual profits, the full redemption of the US Treasury’s Small Business Lending Fund (SBLF) shares while reaffirming its ongoing quarterly cash dividend.

President and CEO John Dalby stated, “In 2015, Redwood Capital Bank was awarded a 5-Star rating from Bauer Financial, one of the most well-known and respected financial rating agencies within the banking trade.   These results and accolades suggest that our focus on putting local deposits to work by making loans to our local business, mortgage and consumer customers is building toward sustainable growth and positive earnings trends for the future.”

Total assets as of December 31, 2015 were $317.1 million, a slight decrease of 2% over the September 30, 2015 figure and a robust increase of 13% over the December 31, 2014 reported figures.  Total deposits stood at $290.1 million as of December 31, 2015, 1% less than the September 30, 2015 figures and 15% higher than the December 31, 2014 numbers.  The company reported strong loan growth for the quarter and year.  Total loans as of December 31, 2015, net of unearned income, were $223.6 million, an increase of 3% over the prior quarter and 9% over the year ended December 31, 2014.

Consolidated net interest income for the three and twelve months ended December 31, 2015 totaled $2,829,000 and $10,955,000, up 2% from the figure reported for the three months ended September 30, 2015 and up a strong 10% for the twelve months ended December 31, 2014.  The company also reported net income for the fourth quarter of 2015 of $617,000, while record earnings for the year ended December 31, 2015 were reported as $2,274,000.  The earnings represented a 3% decrease over the September 30, 2015 quarter and a strong increase of 13% over the year ended December 31, 2014. 

The company also announced that it has redeemed all of the shares issued to the US Treasury in July, 2011 under the Treasury’s SBLF program.  Utilizing the funds from the SBLF, the company was able to grow its small business loans in the local area by more than $17 million.  The redemption, approved by all appropriate regulatory authorities, was made possible, in part, by five years of record earnings, reflecting the company’s successful execution of its growth strategy.  After redemption, the company’s capital ratios remain well in excess of the capital ratios required to meet the regulatory “standard” designation.

Additionally, the Board of Directors declared a quarterly cash dividend of $0.06 per share, payable on February 4, 2016 to shareholders of record at the close of business on January 25, 2016.  The dividend is equivalent to an annual rate of $0.24 per share or 2.09%, based upon a market price of $11.50 per common share.  Since January 27, 2015 the rise in the company’s stock price, combined with dividends, has generated a total return of over 19%.

“We are very pleased with the opportunity to enhance shareholder value by deploying excess capital in a sound manner consistent with the desire of our Board of Directors and our shareholders at large.  We continue to be a well-capitalized organization with the ability to take advantage of strategic opportunities as they arise.  The entire Redwood Capital Bank team is excited about the opportunities before us in 2016,” Dalby concluded.

For more information regarding Redwood Capital Bancorp, please visit our website at www.redwoodcapitalbank.com , contact Fred Moore, CFO, at (707) 444-9840, or stop by our headquarters and main office at 402 “G” Street, Eureka, CA 95501.  

This press release may contain forward-looking statements that are subject to risks and uncertainties. Such risks and uncertainties may include but are not necessarily limited to fluctuations in interest rates, inflation, government regulations and general economic conditions, and competition within the business areas in which the bank is conducting its operations, including the real estate market in California and other factors beyond the bank’s control. Such risks and uncertainties could cause results for subsequent interim periods or for the entire year to differ materially from those indicated. Readers should not place undue reliance on the forward-looking statements, which reflect management’s view only as of the date hereof. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect subsequent events or circumstances.      

 

 
Redwood Capital Bancorp
Selected Consolidated Financial Results - Unaudited
( In Thousands - except share data )
           
           
    Period Ended %  
    12/31/2015 9/30/2015 Change  
           
Balance Sheet Data (at period end)        
        Total assets $ 317,134   $ 322,196     -2 %  
  Total deposits   290,086     292,615     -1 %  
  Total loans (net)   223,587     217,664     3 %  
  Common equity   19,541     19,051     3 %  
  Common shares outstanding   1,882,143     1,882,143     0 %  
           
Summary of Operations (Current Quarter)          
  Interest income     3,031       2,959     2 %  
  Interest expense     202       185     9 %  
  Net Interest Income     2,829       2,774     2 %  
  Non-interest income     357       413     -14 %  
  Non-interest expense     2,096       2,027     3 %  
  Net Income before provision     1,090       1,160     -6 %  
  Provision for loan losses     80       120     -33 %  
  Income before taxes     1,010       1,040     -3 %  
  Income taxes     393       402     -2 %  
  Net Income     617       638     -3 %  
  Earnings per share (fully diluted) $ 0.33   $ 0.34     -3 %  
  Book value per common share $ 10.38   $ 10.12     2.6 %  
           
           
    Period Ended %  
    12/31/2015 12/31/2014 Change  
           
Balance Sheet Data (at period end)        
  Total assets $ 317,134   $   280,134     13 %  
  Total deposits   290,086     251,812     15 %  
  Total loans (net)   223,587     205,182     9 %  
  Common equity   19,541     17,478     12 %  
  Common shares outstanding   1,882,143     1,861,411     1 %  
           
Summary of Operations (Current Quarter)        
  Interest income     3,031       2,779     9 %  
  Interest expense     202       161     25 %  
  Net Interest Income     2,829       2,618     8 %  
  Non-interest income     357       291     23 %  
  Non-interest expense     2,096       2,061     2 %  
  Net Income before provision     1,090       848     29 %  
  Provision for loan losses     80       138     -42 %  
  Income before taxes     1,010       710     42 %  
  Income taxes     393       263     -50 %  
  Net Income     617       447     38 %  
  Earnings per share (fully diluted) $ 0.33   $ 0.24     36 %  
  Book value per common share $ 10.39   $ 9.40     11 %  
           
Summary of Operations (Year to Date)        
  Interest income     11,681       10,575     10 %  
  Interest expense     726       629     15 %  
  Net Interest Income     10,955       9,947     10 %  
  Non-interest income     1,409       1,221     15 %  
  Non-interest expense     8,332       7,693     8 %  
  Net Income before provision     4,032       3,475     16 %  
  Provision for loan losses     420       438     -4 %  
  Income before taxes     3,612       3,038     19 %  
  Income taxes     1,338       1,027     30 %  
  Net Income     2,274       2,011     13 %  
  Earnings per share (fully diluted) $ 1.21   $ 1.08     12 %  
  Book value per common share $ 10.38   $ 9.39     11 %  

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 352

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 377

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 225

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Scent Dispensing Solution for Hunting Enthusiasts

Updated Category News Views 168

Introducing a Game-Changing Scent Dispensing System In the world of hunting, attracting game animals can often be a challenge. A new invention, designed specifically for this purpose, promises to make the process much simpler and more efficient. The inventor of this innovative scent dispensing system, THE DRAG LINE PRO, envisioned a better way to utilize a scent drag...

Continue Reading
Corby Spirit and Wine Limited Reports Impressive Fiscal Results

Updated Category News Views 295

Corby Spirit and Wine Limited Announces Strong Fiscal Performance Corby Spirit and Wine Limited, renowned for its position as a leading Canadian manufacturer, marketer, and importer of spirits, has recently unveiled impressive results for its fourth quarter and full-year fiscal 2025. The company demonstrated significant growth in revenue, achieving total revenues of...

Continue Reading
Sezzle Faces Setback as Short-Seller Targets Its Practices

Updated Category News Views 113

Sezzle's Stock Takes a Dramatic Hit Recently, the buy now, pay later (BNPL) provider Sezzle experienced a significant decrease in its stock value. Reports indicate that shares fell over 28.6% in early trading after Hindenburg Research disclosed a short position against the company due to concerns surrounding risky lending practices. Understanding the Short-Selling...

Continue Reading
Exploring the Growth of $1000 in Marsh & McLennan Cos Today

Updated Category News Views 116

Understanding Long-Term Investment in Marsh & McLennan Marsh & McLennan Cos (NYSE: MMC) has established itself as a financial powerhouse, outperforming the market consistently over the past two decades. Investors have experienced an impressive annualized return of 13.31%, showcasing the benefits of long-term investment strategies. The Value of Persistence in Investing...

Continue Reading
Discover Toll Brothers' Latest Luxury Homes at Overbrook Estates

Updated Category News Views 671

Introducing Overbrook Estates by Toll Brothers Toll Brothers, Inc. (NYSE:TOL), a renowned name in luxury homebuilding, excitedly unveils its newest community: Overbrook Estates. This anticipated project is set to grace the Huntersville area, offering homebuyers elegant living in a master-planned environment. Positioned conveniently off Highway 77, this prime location sets...

Continue Reading